GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Asensus Surgical Inc (AMEX:ASXC) » Definitions » FCF Margin %

ASXC (Asensus Surgical) FCF Margin % : -644.31% (As of Jun. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Asensus Surgical FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Asensus Surgical's Free Cash Flow for the three months ended in Jun. 2024 was $-14.22 Mil. Asensus Surgical's Revenue for the three months ended in Jun. 2024 was $2.21 Mil. Therefore, Asensus Surgical's FCF Margin % for the quarter that ended in Jun. 2024 was -644.31%.

As of today, Asensus Surgical's current FCF Yield % is -60.10%.

The historical rank and industry rank for Asensus Surgical's FCF Margin % or its related term are showing as below:

ASXC' s FCF Margin % Range Over the Past 10 Years
Min: -8859.6   Med: -849.67   Max: -204.39
Current: -579.15


During the past 13 years, the highest FCF Margin % of Asensus Surgical was -204.39%. The lowest was -8859.60%. And the median was -849.67%.

ASXC's FCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -4.425 vs ASXC: -579.15


Asensus Surgical FCF Margin % Historical Data

The historical data trend for Asensus Surgical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asensus Surgical FCF Margin % Chart

Asensus Surgical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -866.50 -1,470.17 -510.53 -849.67 -748.37

Asensus Surgical Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,670.49 -1,411.48 -247.60 -1,247.37 -644.31

Competitive Comparison of Asensus Surgical's FCF Margin %

For the Medical Devices subindustry, Asensus Surgical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asensus Surgical's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Asensus Surgical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Asensus Surgical's FCF Margin % falls into.



Asensus Surgical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Asensus Surgical's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-64.188/8.577
=-748.37 %

Asensus Surgical's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-14.22/2.207
=-644.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asensus Surgical FCF Margin % Related Terms

Thank you for viewing the detailed overview of Asensus Surgical's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Asensus Surgical Business Description

Traded in Other Exchanges
N/A
Address
1 TW Alexander Drive, Suite 160, Durham, NC, USA, 27703
Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.
Executives
Starling William N Jr director 2300 BUCKSKIN ROAD, POCATELLO ID 83201
Andrea Biffi director C/O SOFAR SPA, VIA FIRENZE 40, TREZZANO ROSA (MI) L6 20060
Elizabeth Kwo director C/O FLEXION THERAPEUTICS, INC., 10 MALL ROAD, SUITE 301, BURLINGTON MA 01803
David Bruce Milne director ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON MA 02108
Kevin J Hobert director 343 STATE STREET, ROCHESTER NY 14650
Fernando Anthony C. J. officer: Chief Technology Officer 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27560
Rampertab Shameze officer: EVP, Chief Financial Officer C/O ZOMEDICA PHARMACEUTICALS CORP., 3928 VARSITY DRIVE, ANN ARBOR MI 48108
Brett Farabaugh officer: Interim CFO 108 T.W. ALEXANDER DRIVE, RESEARCH TRIANGLE PARK NC 27709
Joseph P Slattery officer: EVP and CFO C/O TRANSENTERIX, INC., 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27560
Eric A Smith officer: Chief Commercial Officer 7 CALEB CIRCLE, SAN ANTONIO TX 78258
Todd Pope director, officer: President and CEO C/O TRANSENTERIX, 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27713
Willam N Kelley director MERCK & CO., INC., ONE MERCK DRIVE, WHITEHOUSE STATION X1 08889
Pfenniger Richard C Jr director 4400 BISCAYNE BLVD., MIAMI FL 33137
Sofar, S.p.a 10 percent owner VIA FIRENZE 40, TREZZANO ROSA L6 20060
Andrew N Schiff director, 10 percent owner PLANET ZANETT INC, 135 E 57TH ST, NEW YORK NY 10022

Asensus Surgical Headlines

From GuruFocus

Q4 2019 Transenterix Inc Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q3 2020 Transenterix Inc Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q2 2020 Transenterix Inc Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q1 2021 Asensus Surgical Inc Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q3 2022 Asensus Surgical Inc Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q2 2024 Asensus Surgical Inc Earnings Call Transcript

By GuruFocus Research 08-14-2024

Q4 2023 Asensus Surgical Inc Earnings Call Transcript

By GuruFocus Research 03-22-2024

Q3 2021 Asensus Surgical Inc Earnings Call Transcript

By GuruFocus Research 02-12-2024